欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FI/H/1194/001
药品名称Cyclophosphamide Accord
活性成分
    • Cyclophosphamide 200.0 mg/ml
剂型Concentrate for solution for injection/infusion
上市许可持有人Accord Healthcare Winthontlaan 200, 3526 KW Utrecht Netherlands
参考成员国 - 产品名称Finland (FI)
Cyclophosphamide Accord
互认成员国 - 产品名称
    • Latvia (LV)
    • Lithuania (LT)
    • Germany (DE)
      Cyclophosphamid Accord 200 mg/ml Konzentrat zur Herstellung einer Injektions-/Infusionslösung
    • Estonia (EE)
    • Denmark (DK)
    • Bulgaria (BG)
    • Belgium (BE)
      Cyclofosfamide Accord 200 mg/ml concentraat voor oplossing voor injectie/infusie
    • Cyprus (CY)
      Cyclophosphamide Accord 200 mg/ml concentrate for solution for injection/infusion
    • France (FR)
    • Czechia (CZ)
      Cyclophosphamide Accord
    • Spain (ES)
    • Romania (RO)
    • Portugal (PT)
    • Croatia (HR)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Poland (PL)
      Cyclophosphamide Accord
许可日期2024/03/13
最近更新日期2024/11/21
药物ATC编码
    • L01AA01 cyclophosphamide
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase